Discontinuation report THEOLAIR
| Report ID | 138081 |
| Drug Identification Number | 01966219 |
| Brand name | THEOLAIR |
| Common or Proper name | Theophylline solution |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | THEOPHYLLINE |
| Strength(s) | 80MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 500 mL |
| ATC code | R03DA |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-04-26 |
| Remaining supply date | 2019-11-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-04-26 | English | Compare |
| v2 | 2021-04-26 | French | Compare |
| v3 | 2021-04-27 | English | Compare |
Showing 1 to 3 of 3